ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026
Clinical implementation of automated IMRT/VMAT planning for lung cancer radiation therapy using the expedited constrained hierarchical optimization (ECHO) system.
Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
purposeTo develop, clinically implement, and use automated treatment planning for lung cancer radiotherapy (RT) via an in-house treatment planning optimization system, the expedited constrained hierarchical optimization (ECHO).
methodsThe ECHO system accepts segmented tumor and normal tissue contours and clinical dose/volume criteria as inputs and generates optimized fluence maps for intensity-modulated RT (IMRT) and leaf trajectories for volumetric-modulated arc therapy (VMAT). Dose/volume criteria for our clinically used seven lung cancer fractionation schedules were implemented in ECHO. For each schedule, ECHO internal optimization parameters were tuned using 5-7 previously treated patients and validated with additional 20-25 patients.
resultsSince May 2021, a total of 431 lung cancer patients have been treated with ECHO IMRT. Additionally, from April 2023, 93 lung SBRT patients were planned with ECHO VMAT. Treatment plans optimized with ECHO IMRT and VMAT provide more consistent target coverage and similar organ sparing compared with manually optimized plans. The average planning target volume was 390 cm
conclusionsWe have implemented an automated system for lung RT treatment planning at our institution for seven fractionation schedules. Our ECHO approach is robust and adapts to changes in clinical criteria without requiring algorithm modifications or retraining. The proposed treatment planning automation framework saves resources and improves treatment plan quality and consistency.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.